Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Betere therapie voor cervixcarcinoom door afremmen DNA-reparatie tumorcellen
apr 2017 | Gynaecologische oncologie